Novartis
NVS
#58
Rank
S$347.34 B
Marketcap
S$182.74
Share price
-0.47%
Change (1 day)
7.23%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

P/S ratio for Novartis (NVS)

P/S ratio as of October 2026 (TTM): 4.80

According to Novartis's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.49. At the end of 2026 the company had a P/S ratio of 5.23.

P/S ratio history for Novartis from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20265.2311.51%
20254.6923.33%
20243.80-14.5%
20234.4513.44%
20223.925.53%
20213.72-14.86%
20204.36-1.11%
20194.417.08%
20184.124.79%
20173.9312.4%
20163.50-15.42%
20154.14-0.95%
20144.1819.64%
20133.4931.91%
20122.6513.79%
20112.33-10.9%
20102.61-5.84%
20092.774.75%
20082.65-16.59%
20073.17-17.67%
20063.852.02%
20053.78-13%
20044.34-4.67%
20034.5516.84%
20023.90-18.42%
20014.78

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.36 32.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.51-47.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.81-20.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.69-64.73%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
5.29 10.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.48-48.39%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.05-15.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2.12-55.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
2.64-45.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel